ICH Q8 (R2) Pharmaceutical development

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/167068/2004
Effective from01/05/2006
KeywordsPharmaceutical development, quality, quality by design, enhanced approach, design space, proven acceptable ranges, process analytical technology, risk assessment, control strategy
DescriptionThis document describes the suggested contents for the 3.2.P.2 (Pharmaceutical Development) section of a regulatory submission in the ICH M4 Common Technical Document (CTD) format. The guideline also indicates areas where the demonstration of greater understanding of pharmaceutical and manufacturing sciences can create a basis for flexible regulatory approaches.

Related content

How helpful is this page?

Average rating:

 Based on 32 ratings

Add your rating:

See all ratings
6 ratings
6 ratings
7 ratings
6 ratings
7 ratings

Tell us more